14.04.2015
![]()
DGAP-Adhoc: SARTORIUS AG: Dynamic First Quarter | Forecast Revised Upwards
SARTORIUS AG / Key word(s): Development of Sales/Development of Sales
14.04.2015 14:55
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
In the first quarter of 2015, the Sartorius Group achieved sales growth of
around 17% in constant currencies based on preliminary figures, reaching
approximately EUR258 million in consolidated revenue (reported gain: around
27%).
This growth was driven primarily by the Bioprocess Solutions Division. Due
to the low prior-year revenue base, the company had expected above-average
growth rates for this first quarter. Nevertheless, the gains supported by
strong performance in all product segments were higher than projected at
the beginning of the year.
Based on the results of the first three months, Sartorius has revised its
forecast upwards for the full year of 2015. Sales revenue in constant
currencies is now expected to increase by approximately 6% to 9% (previous
guidance: approx. 4% to 7%). Management projects that the company's
underlying EBITDA margin in constant currencies will increase to around 22%
(previous guidance: around 21.5%).
Further information will be published as part of the company's
first-quarter reporting activities on April 20, 2015.
Goettingen, Germany, April 14, 2015
This ad hoc announcement contains statements about the future development
of the Sartorius Group. The content of these statements cannot be
guaranteed as they are based on assumptions and estimates that harbor
certain risks and uncertainties. This is a translation of the original
German-language ad hoc announcement. Sartorius shall not assume any
liability for the correctness of this translation. The original German ad
hoc announcement is the legally binding version. Furthermore, Sartorius
reserves the right not to be responsible for the topicality, correctness,
completeness or quality of the information provided. Liability claims
regarding damage caused by the use of any information provided, including
any kind of information which is incomplete or incorrect, will therefore be
rejected.
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
Contact
Petra Kirchhoff
Vice President of Group Corporate Communications and IR
+49 (0)551.308.1686
[email protected]
14.04.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: SARTORIUS AG
Weender Landstraße 94 - 108
37075 Göttingen
Germany
Phone: +49.(0)551-308.0
Fax: +49.(0)551-308.3289
E-mail: [email protected]
Internet: www.sartorius.com
ISIN: DE0007165607, DE0007165631
WKN: 716560 , 716563
Listed: Regulated Market in Frankfurt (Prime Standard), Hanover;
Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg,
Munich, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
SARTORIUS AG ISIN: DE0007165607 können Sie bei EQS abrufen
Medtech , 716560 , SRT , XETR:SRT